Variability in the analysis of 25-hydroxyvitamin D by liquid chromatography-tandem mass spectrometry: The devil is in the detail

被引:52
作者
Couchman, Lewis [1 ]
Benton, Christopher M. [1 ]
Moniz, Cajetan F. [1 ]
机构
[1] Kings Coll Hosp NHS Fdn Trust, Dept Clin Biochem, London SE5 9RS, England
关键词
25-Hydroxyvitamin D; LC-MS/MS; Standardisation; DEQAS; VITAMIN-D STATUS; CIRCULATING; 25-HYDROXYVITAMIN-D; SAMPLE PREPARATION; LC-MS/MS; D ASSAYS; ACCURACY; SERUM; BIOANALYSIS; METABOLITES; INFANTS;
D O I
10.1016/j.cca.2012.04.003
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is increasingly used in clinical laboratories for the analysis of 25-hydroxyvitamin D (25OHD), but measurement is not straightforward. Importantly. LC-MS/MS is not a single technique: variables in sample preparation, chromatography and ionisation/fragmentation should each be considered. Methods: We analysed results from a survey organised by the international Vitamin D External Quality Assessment Scheme (DEQAS), to determine the influence of such variables on the results for two DEQAS distributions. Results: 65 laboratories returned questionnaires. 346 (57%) individual results were from laboratories using electrospray ionisation (ESI), and 259 (43%) from laboratories using atmospheric pressure chemical ionisation (APCI). Although the mean ratio of results was not significantly different between ESI and APCI (P = 0.5828), there was greater variation (P<0.0001) in results obtained by laboratories using ESI. Greater variation (P<0.05) was also observed between results from laboratories monitoring non-specific water-loss transitions. Only 3 laboratories (5%) could resolve the isobaric metabolite 3-epi-25OHD(3) from 25OHD(3). Conclusions: There are many variables to consider when using LC-MS/MS, including assay standardisation/calibration, chromatography and MS conditions. MS/MS alone cannot distinguish isobaric metabolites such as 3-epi-25OHD(3). Interference can also occur if non-specific transitions are used. Laboratories should always subscribe to an EQA scheme for 25OHD analysis. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:1239 / 1243
页数:5
相关论文
共 34 条
[1]   Ion suppression in mass spectrometry [J].
Annesley, TM .
CLINICAL CHEMISTRY, 2003, 49 (07) :1041-1044
[2]   Assay variation confounds the diagnosis of hypovitaminosis D: A call for standardization [J].
Binkley, N ;
Krueger, D ;
Cowgill, CS ;
Plum, L ;
Lake, E ;
Hansen, KE ;
DeLuca, HF ;
Drezner, MK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07) :3152-3157
[3]  
Bonfiglio R, 1999, RAPID COMMUN MASS SP, V13, P1175, DOI 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.0.CO
[4]  
2-0
[5]   Measurement of vitamin D metabolites: an international perspective on methodology and clinical interpretation [J].
Carter, GD ;
Carter, CR ;
Gunter, E ;
Jones, J ;
Jones, G ;
Makin, HLJ ;
Sufi, S .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 89-90 (1-5) :467-471
[6]   How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme [J].
Carter, GD ;
Carter, R ;
Jones, J ;
Berry, J .
CLINICAL CHEMISTRY, 2004, 50 (11) :2195-2197
[7]  
Carter GD, 2011, CURR DRUG TARGETS, V12, P19
[8]   25-Hydroxyvitamin D Assays: The Quest For Accuracy [J].
Carter, Graham D. .
CLINICAL CHEMISTRY, 2009, 55 (07) :1300-1302
[9]   Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D [J].
Carter, Graham D. ;
Jones, Julia C. .
ANNALS OF CLINICAL BIOCHEMISTRY, 2009, 46 :79-81
[10]   Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method [J].
Chen, Huiping ;
McCoy, Leslie F. ;
Schleicher, Rosemary L. ;
Pfeiffer, Christine M. .
CLINICA CHIMICA ACTA, 2008, 391 (1-2) :6-12